title: Human papillomavirus vaccines six years after approval.
abstract: Human papillomavirus vaccines were developed beginning in the early 1990s. Two similar vaccines were approved in 2006 and 2009 following extensive clinical testing. Both vaccines prevent HPV infection. Implementation of these vaccines is the next challenge.
authors.affiliation: Vedantra Pharmaceuticals, Cambridge, Massachusetts 02139, USA. alan.shaw@vedantra.com
authors.forename: Alan R
authors.initials: AR
authors.lastname: Shaw
mesh_terms: D017277:Drug Approval; D006801:Humans; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D012189:Retrospective Studies
chemical_list: D053918:Papillomavirus Vaccines